XML 76 R31.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of Loss Before Provision (Benefit) for Income Taxes Our loss before provision (benefit) for income taxes for the years ended December 31, 2022 and 2021 consisted of the following (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2022

 

 

2021

 

Domestic

 

$

(1,885

)

 

$

206

 

Foreign

 

 

(68,300

)

 

 

(68,017

)

Total

 

$

(70,185

)

 

$

(67,811

)

Schedule of Provision for Income Taxes

Our provision for income taxes consists of the following (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2022

 

 

2021

 

Current:

 

 

 

 

 

 

Federal

 

$

1,059

 

 

$

114

 

State

 

 

86

 

 

 

23

 

Foreign

 

 

52

 

 

 

18

 

 

 

 

1,197

 

 

 

155

 

Deferred:

 

 

 

 

 

 

Federal

 

 

76

 

 

 

(72

)

State

 

 

 

 

 

(15

)

Foreign

 

 

 

 

 

 

 

 

 

76

 

 

 

(87

)

Total provision for income taxes

 

$

1,273

 

 

$

68

 

 

Reconciliation of the Statutory Income Tax Rate to our Effective Income Tax Rate The reconciliation of the statutory income tax rate to our effective income tax rate is as follows:

 

 

 

Year Ended December 31,

 

 

 

2022

 

 

2021

 

Income tax benefit at the statutory rate

 

 

21.0

%

 

 

21.0

%

Permanent differences

 

 

0.7

 

 

 

(6.5

)

Difference in tax rate

 

 

1.0

 

 

 

1.0

 

R&D Deduction

 

 

4.0

 

 

 

 

Change in valuation allowance

 

 

(27.4

)

 

 

(15.6

)

Other

 

 

(1.1

)

 

 

 

Total

 

 

(1.8

)%

 

 

(0.1

)%

Schedule of Principal Components of Deferred Tax Assets The principal components of the Company’s deferred tax assets consisted of the following (in thousands):

 

 

 

December 31,

 

 

 

2022

 

 

2021

 

Deferred tax assets:

 

 

 

 

 

 

Net operating loss carryforwards

 

$

31,338

 

 

$

14,693

 

Equity-based compensation expense

 

 

1,828

 

 

 

345

 

Accrued compensation

 

 

21

 

 

 

88

 

ROU Lease Liability

 

 

618

 

 

 

 

Capitalized R&D

 

 

1,231

 

 

 

 

Other

 

 

529

 

 

 

73

 

Total deferred tax assets

 

$

35,565

 

 

$

15,199

 

Valuation allowance

 

 

(34,984

)

 

 

(15,112

)

Net deferred tax assets

 

$

581

 

 

$

87

 

ROU Lease Asset

 

 

567

 

 

 

 

Other Liabilities

 

 

14

 

 

 

 

Total deferred tax liabilities

 

 

581

 

 

 

 

Net deferred tax asset (liability)

 

$

 

 

$

87

 

In 2017, the U.S. enacted the Tax Cuts and Jobs Act (the 2017 Tax Act), which contained a provision that requires capitalization and amortization of research and development expenses for tax purposes starting in 2022. Previously, these expenses could be deducted in the year incurred. The implementation of this provision increased our deferred tax asset and valuation allowance by approximately $1.2 million in 2022.